Zomedica Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Zomedica Corp inventory turnover ratio, the Zomedica Corp 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.87 in the first quarter 2026, ZOMDF's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Zomedica in Mar 31 2026 quarter, has decreased to 195 days, compare to 210 days, in the Dec 31 2025 quarter.

Within Healthcare sector 181 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the First Quarter 2026 compared to previous quarter at no. 1237.

ZOMDF Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Zomedica Corp Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ZOMDF Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	9.65 %	9.63 %	1.71 %	3 %	5.85 %
Y / Y Cost of Sales Growth	50 %	-17.47 %	100 %	129.8 %	0 %
Inventory Turnover Ratio (TTM)	1.87	1.74	1.91	1.73	1.5
ZOMDF's Total Ranking	# 1237	# 1237	# 1237	# 1237	#
Average inventory processing period	195	210	191	211	244
Seq. Inventory Growth	5.95 %	0.42 %	-2.64 %	5.86 %	5.93 %
Seq. Cost of Sales Growth	-9.12 %	65.05 %	-12.97 %	14.9 %	-50 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 50
Healthcare Sector	# 182
Overall Market	# 1237

Inventory Turnover Ratio Statistics
High	Average	Low
2.18	1.47	0
(Mar 31 2026)		(Dec 31 2021)

ZOMDF Company Profile >> Back to ZOMDF Efficiency Comparisons >> Compare ZOMDF Inventory Turnover Ratio to its Competitors

Financial Statements
Zomedica 's Inventories	$ 6 Millions	Visit ZOMDF's Balance sheet
Zomedica 's Cost of Revenues TTM	$ 11 Millions	Visit ZOMDF's Income Statement
What are ZOMDF's Sales?		Visit ZOMDF's Sales by Segment

Other Inventory Turnover Ratios
Zomedica 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ZOMDF's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ZOMDF's Competitors
Inventory Turnover Ratio for ZOMDF's Suppliers
Inventory Turnover Ratio for ZOMDF's Customers

You may also want to know
ZOMDF's Sales Growth Rates	ZOMDF's Pe Price to earnings ratio	ZOMDF's Receivables Turnover Ratio	ZOMDF's Stock Quote
ZOMDF's Net Income Growth Rates	ZOMDF's Ps Price to Sales ratio	ZOMDF's Sales per Employee	ZOMDF's Asset Turnover Ratio
ZOMDF's Net Margin	ZOMDF's Pb Price to Book ratio	ZOMDF's Financial Strength Ratios	ZOMDF's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Integrated Biopharma Inc	4.96	$ 45.000 Millions	$ 9 Millions
Ufp Technologies Inc	4.95	$ 436.000 Millions	$ 88 Millions
Polomar Health Services, Inc.	4.79	$ 0.642 Millions	$ 0 Millions
Henry Schein Inc	4.70	$ 9,209.000 Millions	$ 1,959 Millions
Bionexus Gene Lab Corp	4.70	$ 4.191 Millions	$ 1 Millions
Medinotec Inc	4.69	$ 4.864 Millions	$ 1 Millions
West Pharmaceutical Services Inc	4.68	$ 2,052.000 Millions	$ 439 Millions
Scilex Holding Company	4.48	$ 14.462 Millions	$ 3 Millions
Guardant Health Inc	4.41	$ 379.203 Millions	$ 86 Millions
Idexx Laboratories Inc	4.38	$ 1,690.942 Millions	$ 386 Millions
Envista Holdings Corporation	4.36	$ 1,267.000 Millions	$ 290 Millions
Inotiv Inc	4.25	$ 175.895 Millions	$ 41 Millions
Cryoport inc	4.23	$ 96.609 Millions	$ 23 Millions
Teva Pharmaceutical Industries Limited	4.22	$ 8,317.000 Millions	$ 1,971 Millions
Incyte Corporation	4.21	$ 403.465 Millions	$ 96 Millions
Electromed Inc	4.16	$ 14.195 Millions	$ 3 Millions
Vericel Corporation	4.15	$ 73.494 Millions	$ 18 Millions
Sharps Technology Inc	4.12	$ 3.585 Millions	$ 1 Millions
Coherus Oncology inc	4.11	$ 14.975 Millions	$ 4 Millions
Novocure Limited	4.08	$ 167.287 Millions	$ 41 Millions
Lifeward ltd	4.08	$ 13.275 Millions	$ 3 Millions
Ge Healthcare Technologies Inc	4.04	$ 9,262.000 Millions	$ 2,294 Millions
Koru Medical Systems Inc	3.99	$ 16.468 Millions	$ 4 Millions
3m Company	3.94	$ 15,087.000 Millions	$ 3,830 Millions
Iridex Corp	3.92	$ 32.247 Millions	$ 8 Millions
Myomo Inc	3.88	$ 14.000 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.84	$ 71.976 Millions	$ 19 Millions
Escalon Medical Corp	3.79	$ 6.698 Millions	$ 2 Millions
Evolus Inc	3.71	$ 103.000 Millions	$ 28 Millions
Abbvie Inc	3.70	$ 18,420.000 Millions	$ 4,975 Millions

Date modified: 2026-08-30T14:57:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.